Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Onconetix Inc (ONCO)

Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,030
  • Shares Outstanding, K 656
  • Annual Sales, $ 820 K
  • Annual Income, $ -14,030 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 3.52
  • Price/Sales 1.56
  • Price/Cash Flow N/A
  • Price/Book 0.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1700 +27.35%
on 03/30/26
6.7300 -77.86%
on 03/27/26
-1.8550 (-55.46%)
since 02/27/26
3-Month
1.1700 +27.35%
on 03/30/26
11.5000 -87.04%
on 01/20/26
-5.6600 (-79.16%)
since 12/26/25
52-Week
1.1700 +27.35%
on 03/30/26
74.2900 -97.99%
on 05/14/25
-37.4825 (-96.18%)
since 03/28/25

Most Recent Stories

More News
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix LLC and Drive Long-Term Shareholder Value CINCINNATI, Ohio, March 31, 2026 (GLOBE NEWSWIRE) -- Onconetix,...

ONCO : 1.4900 (-5.10%)
Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration

Realbotix Humanoid Robot — Ericsson’s First Enterprise Robotics Client — Featured as Live Connected Endpoint in Pre-Standard 6G Over-the-Air Trial at Ericsson’s U.S. Headquarters; Onconetix Has...

ONCO : 1.4900 (-5.10%)
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

CINCINNATI, Ohio, March 23, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development,...

ONCO : 1.4900 (-5.10%)
Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Parent Company”), a leader in AI-powered humanoid robots, announces it has entered into a definitive agreement...

XBOTF : 0.2080 (-0.19%)
XBOT.VN : 0.290 (+3.57%)
ONCO : 1.4900 (-5.10%)
Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

A leading AI and humanoid robotics company has commercially available models designed, built and manufactured in the United States of America  CINCINNATI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Onconetix,...

ONCO : 1.4900 (-5.10%)
Onconetix Completes PIPE Financing Transaction

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

ONCO : 1.4900 (-5.10%)
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and...

ONCO : 1.4900 (-5.10%)
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company focused on innovative solutions for men's health and oncology,...

ONCO : 1.4900 (-5.10%)
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

CINCINNATI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and commercialization...

ONCO : 1.4900 (-5.10%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders

NEW YORK , July 18, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WAT : 297.80 (+1.51%)
ONCO : 1.4900 (-5.10%)
XAGE : 0.2929 (-24.90%)

Business Summary

Onconetix Inc. is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. Onconetix Inc., formerly known as Blue Water Biotech Inc., is based in CINCINNATI.

See More

Key Turning Points

3rd Resistance Point 2.4033
2nd Resistance Point 2.0767
1st Resistance Point 1.8233
Last Price 1.4900
1st Support Level 1.2433
2nd Support Level 0.9167
3rd Support Level 0.6633

See More

52-Week High 74.2900
Fibonacci 61.8% 46.3582
Fibonacci 50% 37.7300
Fibonacci 38.2% 29.1018
Last Price 1.4900
52-Week Low 1.1700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.